Financial Year |
March 31 2023 |
Monetary Funds |
730,875,167.57 |
Held-for-trading Financial Assets |
101,243.30 |
Notes Receivable |
1,091,436,233.18 |
Accounts Receivable |
2,215,041,044.75 |
Advances to Suppliers |
99,403,601.92 |
Other Receivables |
66,737,417.11 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
3,133,160,329.56 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
85,965,918.08 |
Total Current Assets |
7,902,579,212.83 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
12,532,787.29 |
Fixed Assetes |
3,467,963,112.69 |
Under-construction Projects |
252,113,503.78 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
478,443,113.27 |
R&D expenses |
736,170.96 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
18,428,426.25 |
Deferred Income Tax Assets |
105,408,093.14 |
Other Non-Current Assets |
195,415,560.25 |
Sub-Total of Non-Current Assets |
4,638,061,043.00 |
Total Assets |
12,540,640,255.83 |
Short-Term Loans |
929,788,645.97 |
Trading Financial liabilities |
4,871,308.54 |
Notes Payable |
96,508,764.12 |
Accounts Payable |
1,264,916,203.25 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
112,837,433.95 |
Taxes Payable |
53,034,788.69 |
Interest Payable |
2,448,943.07 |
Dividend Payable |
755,034.53 |
Other payables |
208,514,012.72 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
515,618,951.63 |
Other Current Liabilities |
939,231,973.85 |
Sub-Total of Current Liabilities |
4,361,573,922.71 |
Long-term Loans |
1,445,042,888.89 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
44,751,590.13 |
Other Non-Current Liabilities |
3,046,309.43 |
Sub-Total of Non-Current Liabilities |
1,925,964,915.71 |
Total Liabilities |
6,287,538,838.42 |
Paid-In Capital(Or Share Stock) |
1,075,526,842.00 |
Capital Surplus |
3,530,556,287.94 |
Surplus Reserve |
67,116,750.17 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
922,667,613.97 |
Minority Stockholder's Interest |
756,687,374.29 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,496,414,043.12 |
Owner's Equity(Stockholder's Equity) |
6,253,101,417.41 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
12,540,640,255.83 |